Skip to main content
TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
0.969
+0.129 (15.33%)
At close: Jun 26, 2026, 4:00 PM EDT
0.885
-0.084 (-8.64%)
After-hours: Jun 26, 2026, 6:54 PM EDT

TScan Therapeutics Employees

As of March 31, 2026, TScan Therapeutics had 139 total employees, including 138 full-time and 1 part-time employees. The number of employees decreased by 3 or -2.11% since the number was last reported on December 31, 2025.

Employees
139
Change
-3
Growth
-2.11%
Revenue / Employee
$65,727
Profits / Employee
-$894,281
Market Cap
63.31M

Employees Chart

Employees History

Date Employees Change Growth
Mar 31, 2026139-3-2.11%
Dec 31, 2025142-53-27.18%
Dec 31, 20241954126.62%
Dec 31, 20231541611.59%
Dec 31, 20221383331.43%
Dec 31, 2021 Pro Pro Pro
Dec 31, 2020 Pro Pro Pro

Related Stocks

Company Name Employees
Xilio Therapeutics 76
aTyr Pharma 60
Boundless Bio 28
PDS Biotechnology 21
Filana Therapeutics 20
Instil Bio 17
MiNK Therapeutics 15
Context Therapeutics 15
Employee Rankings

TCRX News

More News